Connecting the New Care Ecosystem. Part 1 of 2.

With the increasing adoption of telemedicine, remote patient monitoring, and digital health technologies, this conversation delves into the transformative potential of connected care and the challenges it presents.

How can healthcare systems leverage technology to deliver care in a more seamless and patient-centered manner? This question serves as the guiding thread throughout the episode, addressing the evolving landscape of healthcare delivery and the role of technology in bridging the gaps.

On the recent episode of Healthcare on Air by Verizon, host Robin Goldsmith, who also serves as Health Innovation Principal at Verizon, invited two leaders in the field to discuss these crucial questions: Dr. Keisuke Nakagawa, Director of Innovation at UC Davis Health and Executive Director of the UC Davis Health Cloud Innovation Center, and Ned Chini, Senior Principal, Digital Health and Health Equity at Verizon.

Main Points of Discussion:

  • The concept of connected care and its impact on healthcare delivery.
  • Challenges in implementing a connected care system, including cultural shifts, workflow adaptations, and reducing clinician burnout.
  • Examples of innovative work at UC Davis Health, such as integrated service lines, to create a more seamless patient experience

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…